Lobashevsky A, Kotb M, Gaber A O
Department of Surgery, University of Tennessee, Memphis 38163, USA.
Transplantation. 1996 Nov 15;62(9):1332-40. doi: 10.1097/00007890-199611150-00027.
Previous studies have provided strong evidence for restricted Vbeta gene usage in response to DR synthetic peptides presented in context by self MHC molecules, i.e., via the indirect pathway of allorecognition. Although numerous studies have suggested a role for the T cell receptor (TCR) beta chain in the direct pathway of allorecognition, it is not clear whether a particular HLA allele elicits a consistent pattern of restricted Vbeta gene usage by resting T cells from different individuals. To address this problem, HLA class II homozygous cell lines that do not express class I antigens were used to study the role of the TCR Vbeta elements in direct recognition of specific DR alleles. Analysis of TCR V gene usage revealed that each DR allele tested elicited the same pattern of preferential Vbeta gene usage in all individuals studied. For example, the DRB10101 allele was preferentially recognized by T cells expressing Vbeta2, Vbeta13.1, Vbeta18, and Vbeta20, and the DRB11301 caused expansion of Vbeta4-, Vbeta6-, Vbeta8-, and Vbeta18-bearing T cells. Similarly, analysis of TCR V gene usage in response to defined DR alleles expressed on homozygous cell lines that express class I was also made possible by using anti-class I antibodies to block class I recognition and focus the response on the DR molecule. The results showed that the DRB11501 allele expressed on two distinct homozygous lines elicited the preferential expansion of Vbeta2, Vbeta8, and Vbeta13.2 T cells. Similarly, the DRB10301 allele expressed on normal, Epstein-Barr virus-transformed, or transfected fibroblasts was found to elicit the same pattern of Vbeta expansion and to selectively stimulate T cells bearing Vbeta2, Vbeta16, and Vbeta17 elements. In contrast to this highly reproducible pattern of Vbeta gene usage elicited by specific DR alleles, extensive heterogeneity in the CDR3 region was found and no preferential Jbeta or Valpha gene usage was observed in response to any of the DR alleles tested. The data suggest that, similar to the situation with the indirect pathway, TCR Vbeta elements are involved in the direct pathway of allorecognition. Although some overlap may exist, different sets of Vbeta elements may be preferentially used for each of these pathways. Inasmuch as HLA-identical siblings, but not HLA-identical unrelated individuals, express a very similar TCR repertoire, our data suggest that additional factors are involved in shaping the repertoire. Preferential activation of T-cell subsets by specific DR alleles may play an important role in primary alloresponses, e.g., in mixed lymphocyte reactions, and organ transplantation. Elucidation of the Vbeta specificity of each DR allele may have an impact on therapeutic strategies aimed at blocking specific alloresponse and prolonging graft survival in transplant recipients while avoiding the hazardous sequelae of nonspecific immunosuppression.
先前的研究已经提供了强有力的证据,证明在自身MHC分子呈递的DR合成肽的情况下,即通过同种异体识别的间接途径,Vβ基因的使用受到限制。尽管大量研究表明T细胞受体(TCR)β链在同种异体识别的直接途径中发挥作用,但尚不清楚特定的HLA等位基因是否会引发来自不同个体的静息T细胞对Vβ基因使用的一致受限模式。为了解决这个问题,使用不表达I类抗原的HLA II类纯合细胞系来研究TCR Vβ元件在直接识别特定DR等位基因中的作用。对TCR V基因使用情况的分析表明,所测试的每个DR等位基因在所有研究个体中都引发了相同的优先Vβ基因使用模式。例如,DRB10101等位基因优先被表达Vβ2、Vβ13.1、Vβ18和Vβ20的T细胞识别,而DRB11301导致表达Vβ4、Vβ6、Vβ8和Vβ18的T细胞扩增。同样,通过使用抗I类抗体阻断I类识别并将反应聚焦于DR分子,也能够分析对在表达I类的纯合细胞系上表达的特定DR等位基因作出反应时的TCR V基因使用情况。结果表明,在两个不同的纯合系上表达的DRB11501等位基因引发了Vβ2、Vβ8和Vβ13.2 T细胞的优先扩增。同样,发现在正常、爱泼斯坦 - 巴尔病毒转化或转染的成纤维细胞上表达的DRB10301等位基因引发了相同的Vβ扩增模式,并选择性地刺激携带Vβ2、Vβ16和Vβ17元件的T细胞。与特定DR等位基因引发的这种高度可重复的Vβ基因使用模式形成对比的是,在CDR3区域发现了广泛的异质性,并且在对任何测试的DR等位基因作出反应时未观察到优先的Jβ或Vα基因使用情况。数据表明,与间接途径的情况类似,TCR Vβ元件参与同种异体识别的直接途径。尽管可能存在一些重叠,但不同的Vβ元件组可能优先用于这些途径中的每一个。由于HLA相同的兄弟姐妹(而非HLA相同的无关个体)表达非常相似的TCR库,我们的数据表明还有其他因素参与塑造库。特定DR等位基因对T细胞亚群的优先激活可能在初次同种异体反应中起重要作用,例如在混合淋巴细胞反应和器官移植中。阐明每个DR等位基因的Vβ特异性可能会影响旨在阻断特定同种异体反应并延长移植受者移植物存活时间同时避免非特异性免疫抑制有害后果的治疗策略。